VJET
Catheter Precision, Inc.
There isn't enough reported data to score VJET yet.
VJET Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
VJET's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
VJET PE Valuation
VJET has no meaningful PE right now: it lost money over the past year.
VJET Forward outlook
There aren't enough analyst estimates for VJET to show an outlook.
VJET Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$64,805.04 | +$44,178.96 |
| Q2 2023 | -$72,567.99 | +$91,782.01 |
| Q1 2023 | -$96,841.84 | +$164,408.16 |
| Q4 2022 | -$98,705.00 | +$372,495.00 |
| Q3 2020 | -$4,346,250.00 | +$7,528,750.00 |
VJET is still losing money, but far less than before: $64,805.04 per share over the past year, against $11,875,000.00 at its worst in late 2019.
VJET Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1M | +381% |
| Q1 2026 | $432K | +202% |
| Q4 2025 | $238K | +60% |
| Q3 2025 | $226K | +135% |
| Q2 2025 | $212K | +128% |
| Q1 2025 | $143K | +74% |
| Q4 2024 | $149K | +16% |
| Q3 2024 | $96K | -28% |
VJET's revenue is recovering but still below its 2019 peak: $1M last quarter, up 381% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -388% | +1822 points |
| Q1 2026 | -537% | +1963 points |
| Q4 2025 | -4143% | -2096 points |
| Q3 2025 | -1337% | +1641 points |
| Q2 2025 | -2210% | +711 points |
| Q1 2025 | -2500% | +690 points |
| Q4 2024 | -2048% | -19 points |
| Q3 2024 | -2978% | -926 points |
VJET's operating margin was −388% last quarter, up 1822 points from the same quarter a year ago, near the top of its range since 2019.
VJET Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.9M | -$606K |
| Q1 2026 | -$2.8M | -$454K |
| Q4 2025 | -$1.5M | +$1.4M |
| Q3 2025 | -$2.2M | +$585K |
| Q2 2025 | -$2.3M | -$528K |
| Q1 2025 | -$2.3M | -$384K |
| Q4 2024 | -$2.9M | -$957K |
| Q3 2024 | -$2.8M | -$937K |
VJET has burned cash in almost every quarter: −$9M over the past year, against −$10M the year before.
VJET Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +31% | +1.2K shares |
| 1 year | +41% | +1.5K shares |
| 3 years | +86633% | +5.2K shares |
VJET has 5,204 diluted shares, up 41% from a year ago.
VJET Net Leverage
VJET's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
VJET Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.4 | Oversold |
| Stochastic | 0.7 | Oversold |
VJET's weekly RSI is 27 (oversold) and its Stochastic is 1 (oversold).
VJET PE vs Healthcare Sector
VJET has no meaningful PE right now: it lost money over the past year.
VJET Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.92 | 42% below |
| 20 week MA | $2.45 | 78% below |
| 50 week MA | $9.55 | 94% below |
| 100 week MA | $29.5 | 98% below |
| 200 week MA | $689.2 | 100% below |
VJET is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
VJET Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2,113,750.0 | $681,150.0 | -68% |
| 2021 | $681,150.0 | $164,350.0 | -76% |
| 2022 | $164,350.0 | $8,246.0 | -95% |
| 2023 | $8,246.0 | $767.6 | -91% |
| 2024 | $767.6 | $77.3 | -90% |
| 2025 | $77.3 | $16.8 | -78% |
| 2026 YTD | $16.8 | $0.53 | -97% |
VJET has finished every year since 2020 lower, and it's down 97% so far in 2026.